Top Markets
#1 Songbird Songbird +11.52%
#2 pipedog pipedog +7.75%
#3 Collector Crypt Collector Crypt +6.31%
#4 Cryptopia Cryptopia +5.90%
#5 DAPPOS DAPPOS +4.59%
#6 OpenGradient OpenGradient +3.93%
#7 Moolah Moolah +3.64%
#8 Liquity Liquity +3.60%
#9 Pearl Pearl +3.36%
#10 Clearpool Clearpool +3.26%
Coin of the day
Songbird Songbird
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Rang in Aktien #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Aktienkurs
$19.81
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$891.32M
Veränderung (1 Tag)
1.39%
Veränderung (1 Jahr)
5.16%
Land
US
Handel Beta Bionics, Inc. (BBNX)

Kategorie

Healthcare
Aktien-Split-Historie für Beta Bionics, Inc. (BBNX)
Die Aktie Beta Bionics, Inc. (Symbol: BBNX) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 30, 2026 statt.
Eine BBNX-Aktie, die vor dem Aug 30, 2026 gekauft wurde, entspricht heute 0 BBNX-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 9 x285
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 9 x162
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 7 x127
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2 x4
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 0 -
DE